RetroVirox is a privately-held CRO exclusively focused on the virology field. RetroVirox offers a broad menu of antiviral assays in a fee-for-service or F.T.E. pricing modality. Tests routinely performed include in vitro infectivity, replication, and neutralization assays to determine the antiviral activity of experimental drugs and evaluate candidate vaccines and antibodies. Assays with over a dozen different viruses have been validated and are offered to our customers. Since inception RetroVirox has helped hundreds of companies to complete the preclinical discovery needs of their antiviral and vaccine candidates. Our customers include small start up Biotechs to large Pharmaceuticals in five continents. RetroVirox is also developing small-molecule programs to enhance the adaptive immune response against HIV, and inhibitors with anti-cancer activity. More information about the antiviral services offered at RetroVirox is available at this link: https://retrovirox.com/Retrovirox_-_An_Integrated_Antiviral_Company.html RetroVirox is headquartered in San Diego, CA.